PhenomeX (PhenomeX) Price-to-Operating-Cash-Flow : (As of May. 06, 2024)

View and export this data going back to 2020. Start your Free Trial

What is PhenomeX Price-to-Operating-Cash-Flow?

As of today (2024-05-06), PhenomeX's share price is $0.9981. PhenomeX's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.85. Hence, PhenomeX's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for PhenomeX's Price-to-Operating-Cash-Flow or its related term are showing as below:

CELL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.23
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

PhenomeX's Cash Flow from Operations per share for the three months ended in Jun. 2023 was $-0.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.85.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -51.90% per year.

During the past 5 years, PhenomeX's highest 3-Year average Operating Cash Flow per Share Growth Rate was -46.50% per year. The lowest was -51.90% per year. And the median was -49.20% per year.

PhenomeX Price-to-Operating-Cash-Flow Historical Data

The historical data trend for PhenomeX's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenomeX Price-to-Operating-Cash-Flow Chart

PhenomeX Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

PhenomeX Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of PhenomeX's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, PhenomeX's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhenomeX's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhenomeX's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PhenomeX's Price-to-Operating-Cash-Flow falls into.

PhenomeX Price-to-Operating-Cash-Flow Calculation

PhenomeX's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.9981	/	-0.847
	=

PhenomeX's Share Price of today is $0.9981.
PhenomeX's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

PhenomeX Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PhenomeX's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

PhenomeX (PhenomeX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhenomeX Inc (NAS:CELL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 320, Emeryville, CA, USA, 94608

Website

https://www.phenomex.com

PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.

Executives

Siddhartha Kadia	director, officer: Chief Executive Officer	7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Mehul Joshi	officer: Chief Financial Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Peter Silvester	director	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
John R Chiminski	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Jessica Hopfield	director	C/O 600 TECHNOLOGY PARK DRIVE, SUITE 200, BILLERICA MA 01821
Bird Mergersub Corp	10 percent owner	40 MANNING ROAD, BILLERICA MA 01821
Bruker Corp	10 percent owner	40 MANNING RD, BILLERICA MA 01821
James Paul Mcclaskey	officer: SVP, Chief Accounting Officer	C/O BERKELEY LIGHTS, INC., C/O BERKELEY LIGHTS, INC., EMERYVILLE CA 94608
Scott David Chaplin	officer: Chief Legal Officer	3101 WILSON BOULEVARD, SUITE 700, ARLINGTON VA 22201
Eric Hobbs	director, officer: Chief Executive Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
James Rothman	director	135 EAST 83RD STREET, APT. 15C, NEW YORK NY 10028
Gregory T Lucier	director	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Keith Breinlinger	officer: Chief Technical Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Igor Y Khandros	director, 10 percent owner	25 HACIENDAS ROAD, ORINDA CA 94563
Stuart L Merkadeau	officer: General Counsel	7005 SOUTHFRONT ROAD, LIVERMORE CA 94551